IMC-MAGE-A3 (Immunocore)

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameIMC-MAGE-A3 (Immunocore)
Drug Alias NameIMCmage1MAGE-A3-ImmTACImmTAC-MA GE-A3
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > T cell engagers
Mechanisms of ActionT cell surface glycoprotein CD3 inhibitors
TargetsT cell surface glycoprotein CD3
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunocore Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunocore Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A